Speaker: Dory Abelman, PhD Candidate at the University of Toronto, Department of Medical Biophysics.

Jointly supervised by Dr. Trevor Pugh and Dr. Suzanne Trudel Labs, Princess Margaret Cancer Centre, Toronto, ON

Join Dory Abelman for a talk on research into new, less invasive methods for monitoring multiple myeloma. Dory will discuss how his research uses cell-free DNA (cfDNA) from a blood test to detect genetic changes as a potentially less invasive alternative to bone marrow biopsies. The ultimate goal is to make minimal residual disease (MRD) detection easier and more accessible, improving long-term outcomes for patients. The research also aims to help patients receive important genetic information at diagnosis to better determine their risk and best course of treatment.

Register here